Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Letscher-Bru

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Clinical Microbiology|January 16, 1999
Candida catenulata fungemia in a cancer patientM Radosavljevic, H Koenig, V Letscher-Bru, et al.
Medical Mycology|August 23, 2005
Invasive aspergillosis in the hematologic and immunologic patient: new findings and key questions in leukemiaR Herbrecht, A Moghaddam, L Mahmal, et al.
Infection and Immunity|August 26, 1998
Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in miceV Letscher-Bru, O Villard, B Risse, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 4, 2002
Acremonium strictum pulmonary infection in a leukemic patient successfully treated with posaconazole after failure of amphotericin BR Herbrecht, V Letscher-Bru, C Fohrer, et al.
Parasitology|October 26, 2007
Cellular and molecular physiopathology of congenital toxoplasmosis: the dual role of IFN-gammaA W Pfaff, A Abou-Bacar, V Letscher-Bru, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 18, 2001
Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patientsR Herbrecht, A Auvrignon, E Andrès, et al.
Parasite Immunology|February 1, 2005
Role of gamma interferon and T cells in congenital Toxoplasma transmissionA Abou-Bacar, A W Pfaff, V Letscher-Bru, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 29, 1999
Isolated renal Aspergillus abscess in an AIDS patient with a normal CD4+ cell count on highly active antiretroviral therapyD Rey, E de Mautort, C Saussine, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 20, 2001
Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersionR Herbrecht, V Letscher-Bru, R A Bowden, et al.
Journal of Clinical Microbiology|November 14, 2008
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testingM A Pfaller, D J Diekema, D L Gibbs, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Clinical Microbiology|January 16, 1999
Candida catenulata fungemia in a cancer patientM Radosavljevic, H Koenig, V Letscher-Bru, et al.
Medical Mycology|August 23, 2005
Invasive aspergillosis in the hematologic and immunologic patient: new findings and key questions in leukemiaR Herbrecht, A Moghaddam, L Mahmal, et al.
Infection and Immunity|August 26, 1998
Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in miceV Letscher-Bru, O Villard, B Risse, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 4, 2002
Acremonium strictum pulmonary infection in a leukemic patient successfully treated with posaconazole after failure of amphotericin BR Herbrecht, V Letscher-Bru, C Fohrer, et al.
Parasitology|October 26, 2007
Cellular and molecular physiopathology of congenital toxoplasmosis: the dual role of IFN-gammaA W Pfaff, A Abou-Bacar, V Letscher-Bru, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 18, 2001
Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patientsR Herbrecht, A Auvrignon, E Andrès, et al.
Parasite Immunology|February 1, 2005
Role of gamma interferon and T cells in congenital Toxoplasma transmissionA Abou-Bacar, A W Pfaff, V Letscher-Bru, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 29, 1999
Isolated renal Aspergillus abscess in an AIDS patient with a normal CD4+ cell count on highly active antiretroviral therapyD Rey, E de Mautort, C Saussine, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 20, 2001
Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersionR Herbrecht, V Letscher-Bru, R A Bowden, et al.
Journal of Clinical Microbiology|November 14, 2008
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testingM A Pfaller, D J Diekema, D L Gibbs, et al.
Pageof 3